ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GLYC GlycoMimetics Inc

1.8399
0.1199 (6.97%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.1199 6.97% 1.8399 23:00:05
Open Price Low Price High Price Close Price Previous Close
1.67 1.63 1.84 1.83 1.72
more quote information »

Recent News

Date Time Source Heading
4/25/202406:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
3/27/202406:00BWGlycoMimetics Reports Highlights and Financial Results for..
3/13/202406:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
3/01/202408:16EDGAR2Form 8-K - Current report
2/26/202406:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
2/12/202406:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
1/17/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202406:00BWGlycoMimetics Announces Positive Initial Safety and..
1/03/202406:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
1/02/202415:30EDGAR2Form 8-K - Current report
1/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202311:00BWGlycoMimetics Announces Independent Presentations on..
11/09/202306:00BWGlycoMimetics to Participate in Upcoming Jefferies London..
11/03/202307:35EDGAR2Form 8-K - Current report
11/03/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202306:00BWGlycoMimetics Reports Highlights and Financial Results for..
10/23/202307:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
10/20/202306:00BWGlycoMimetics to Report Third Quarter 2023 Financial Results..
10/03/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202306:00BWGlycoMimetics Announces First Cohort Dosed in Human Phase 1a..
9/05/202306:00BWGlycoMimetics to Participate in Upcoming H.C. Wainwright..
8/17/202306:00BWGlycoMimetics Reports Inducement Grant Under Nasdaq Listing..
8/02/202307:35EDGAR2Form 8-K - Current report
8/02/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202306:00BWGlycoMimetics Reports Highlights and Financial Results for..
7/19/202306:00BWGlycoMimetics to Report Second Quarter 2023 Financial..
6/26/202307:00BWGlycoMimetics Announces Its Addition to the Russell..
6/15/202307:00BWGlycoMimetics Announces U.S. Food and Drug Administration..
5/31/202306:00BWGlycoMimetics to Participate in Upcoming Jefferies 2023..

Your Recent History

Delayed Upgrade Clock